http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0949259-A4
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24a14cc1ad3881d897b18482a3289502 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 |
filingDate | 1997-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e5e7dcd3eeb45ddbd2d588be1a859b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6bbbf397f1435af3735c4796c11cc2ab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1aa5cd6067bb87828327d4958932f4f4 |
publicationDate | 2000-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-0949259-A4 |
titleOfInvention | N-HYDROXYUREA DERIVATIVES AND MEDICINAL COMPOSITIONS BASED ON SUCH DERIVATIVES |
abstract | N-Hydroxyurea derivatives represented by general formula (I), pharmacologically acceptable salts thereof or hydrates or solvates of the same, each having antiallergic or anti-inflammatory effects, wherein one of R1, R3 and R4 represents A while one of the remainders of R1, R3 and R4 and R2 represents 3-pyridyl or 3-pyridylalkyl, and the remainders of R1, R2, R3 and R4 independently represent each H, halogeno or optionally substituted C1-8 alkyl; R5 represents H or lower alkyl; R6 represents H, lower alkyl, C3-7 cycloalkyl or phenyl optionally substituted by halogeno, lower alkyl or lower alkoxy; and B represents a bond, C1-20 alkylene, C2-8 alkenylene or C2-8 alkynylene, or B-C(R5) represents C2-6 alkylene having an intermediate benzene ring. |
priorityDate | 1996-12-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.